FDA Advisory Panel Backs New Lupus Drug Benlysta
At the end of a day of often emotional testimony, an FDA advisory panel overwhelmingly voted to recommend the approval of a new drug for the treatment of systemic lupus.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
